CMQCC Responds to Induction of Labor trial

Following a presentation of the preliminary findings from the “A Randomized Trial of Induction Versus Expectant Management (ARRIVE)” study at the Society for Maternal Fetal Medicine’s annual meeting last week, CMQCC’s Medical Director Elliott Main and the leadership team have released the attached statement.

CMQCC cautions that if a hospital’s induction guidelines are changed to allow for elective inductions at 39 weeks, strict guidelines for defining failed induction and for management of active phase and fetal monitoring abnormalities need to be adopted simultaneously. If labor guidelines and induction failure definitions are not adopted, the cesarean rates will likely rise significantly. Please download the full statement here